Hummingbird Diagnostics - About the company
Hummingbird Diagnostics is a seed company based in Heidelberg (Germany), founded in 2015 by Jochen Kohlhaas. It operates as a Developer of blood tests integrating disease and immune response biomarkers. Hummingbird Diagnostics has raised an undisclosed amount in funding. The company has 99 active competitors, including 28 funded and 16 that have exited. Its top competitors include companies like Biodesix, OncoCyte and Mirvie.
Company Details
Developer of blood tests integrating disease and immune response biomarkers. The company focuses on advancing personalized medicine through integrated analysis of biomarkers. It develops molecular blood tests for early disease detection, treatment monitoring, and prediction of therapeutic response. The company utilizes small RNA biomarkers derived from whole blood samples.
- Phone Number
- +49 **********
Key Metrics
Founded Year
2015
Location
Heidelberg, Germany
Stage
Seed
Latest Funding Round
Investors
Ranked
22nd among 99 active competitors
Employee Count
28 as on Apr 30, 2026
Similar Companies
Legal entities associated with Hummingbird Diagnostics
Hummingbird Diagnostics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Hummingbird Diagnostics Gmbh CIN: HRB701176 , Germany, Active | Nov 06, 2006 | - | 20 (As on Dec 31, 2023) |
Sign up to download Hummingbird Diagnostics' company profile
Hummingbird Diagnostics's funding and investors
Hummingbird Diagnostics has raised funding over 1 round. Its latest funding round was a Seed round on 2016 for $*****. 1 investor participated in its latest round. Hummingbird Diagnostics has 2 institutional investors.
Here is the list of recent funding rounds of Hummingbird Diagnostics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
2016 | 9589 | Seed | 8136 | 6330 | 8157 | 6711 |
View details of Hummingbird Diagnostics's funding rounds and investors
Hummingbird Diagnostics' founders and board of directors
Founder? Claim ProfileThe founders of Hummingbird Diagnostics is Jochen Kohlhaas. Jochen Kohlhaas is the CEO of Hummingbird Diagnostics.
Here are the details of Hummingbird Diagnostics' key team members:
- Jochen Kohlhaas: Co-Founder & CEO of Hummingbird Diagnostics. They serve on the board of 1 company.
Hummingbird Diagnostics' Board of Directors
Hummingbird Diagnostics's board has 1 active member. Cord F Stahler is independent board member.Here is the list of Hummingbird Diagnostics' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
pmypsrw | Team | - | Past | 8y 8m |
Independent board member | - | Current | 19y 6m | |
qwsxlph | Independent board member | - | Past | 5y 2m |
View details of Hummingbird Diagnostics's Founder profiles and Board Members
Hummingbird Diagnostics' employee count trend
Hummingbird Diagnostics has 28 employees as of Apr 26. Here is Hummingbird Diagnostics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Hummingbird Diagnostics's Competitors and alternates
Top competitors of Hummingbird Diagnostics include Biodesix, OncoCyte and Mirvie. Here is the list of Top 10 competitors of Hummingbird Diagnostics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Biodesix 2005, Boulder (United States), Public | Developer of diagnostics assays for the detection of cancer | $200M | 75/100 | |
2nd | OncoCyte 2009, Irvine (United States), Public | Developer of non-invasive diagnostic tests solutions for the treatment of cancer | $15.3M | 66/100 | |
3rd | Mirvie 2019, San Francisco (United States), Series B | Provider of non-invasive diagnostic tests for pregnant women | $114M | 61/100 | |
4th | AI-based oncology therapy plan solution for professionals | $43M | 60/100 | ||
5th | Oxford Cancer Analytics 2018, Oxford (United Kingdom), Series A | Provider of a platform for detection of lung cancer | $16.5M | 60/100 | |
6th | Pacific Edge 2011, Dunedin (New Zealand), Public | - | $1.75M | - | 59/100 |
7th | Provider of liquid biopsy-based molecular diagnostics for cancer detection | $27.9M | 56/100 | ||
8th | Celsee Diagnostics 2011, Plymouth (United States), Acquired | Provider of liquid biopsy technology to monitor circulating tumor cells (CTC) | $40.4M | 55/100 | |
9th | Mursla 2017, London (United Kingdom), Seed | Provider of diagnostic device for cancer detection | $547K | 55/100 | |
10th | Provider of diagnostic tools to support personalized cancer treatment | $6.87M | 54/100 | ||
22nd | Hummingbird Diagnostics 2015, Heidelberg (Germany), Seed | Developer of blood tests integrating disease and immune response biomarkers | - | 44/100 |
Looking for more details on Hummingbird Diagnostics's competitors? Click here to see the top ones
Hummingbird Diagnostics's Investments and acquisitions
Hummingbird Diagnostics has made no investments or acquisitions yet.
News related to Hummingbird Diagnostics
Media has covered Hummingbird Diagnostics for 1 event in last 1 year, It was about people movement.
•
Hummingbird Diagnostics Names Vincent Lozada Chief Executive OfficerBusiness Wire•Jan 12, 2026•Hummingbird Diagnostics
•
•
•
•
•
•
Are you a Founder ?
FAQs about Hummingbird Diagnostics
Explore our recently published companies
- FEiPU - Jing an based, 2021 founded, Unfunded company
- Shenzhen Jiale Technology - Shenzhen based, 2016 founded, Unfunded company
- 32Byte.cn - China based, 2024 founded, Unfunded company
- Goosfraba - Bucharest based, 2020 founded, Unfunded company
- HealthSignz - Hyderabad based, 2014 founded, Unfunded company
- Internetowy Fundusz Leasingowy - Krakow based, 2014 founded, Unfunded company